RAC1 and breast carcinoma: An effect similar to interference with Rac signaling was also observed upon addition of a Rac1 inhibitor to MDA-MB-231 human breast cancer cells, in which the invasiveness of Rac1 inhibitor-treated cancer cells was pronouncedly reduced after three days54.